Pluri Inc.: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 12, 2024 and accepted by EDGAR at Feb 12, 2024, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $105.0k | us-gaap:Revenues |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $159.0k | us-gaap:Revenues |
| Research and development | 3 months2023-10-01 to 2023-12-31 | $3.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-07-01 to 2023-12-31 | $6.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | −$5.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | −$10.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $216.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $430.0k | us-gaap:InterestExpense |
| Net income | 3 months2023-10-01 to 2023-12-31 | −$4.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | −$9.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | −$0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | −$0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 41,526,817 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 41,428,439 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | −$9.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $224.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-12-31 | $5.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $32.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $41.6m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $4.5m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2023-12-31 | $4.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-24-012549. Last ingested by Listed: Oct 30, 2026, 08:31 ET. Listed shows no prices and gives no investment advice.